The Association Between Cytomegalovirus Infection and Atherosclerotic Events in Renal Transplant Recipients

Transplantation Proceedings

Volumn 39, Issue 4, 2007, Pages 990-992

  Ozdemir, F N ^a   Akgul, A ^a   Altunoglu, A ^a   Bilgic, A ^a   Arat, Z ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVASCULARIZATION; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

ADULT; ATHEROSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 34248534495     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.02.026     Document Type: Article

References (13)

1. Aakhus S., Dahl K., and Wideroe T.E. Cardiovascular morbidity and risk factors intransplant patients. Nephrol Dial Transplant 14 (1999) 648
2. Laurés A.S., Gómez E., and Baltar J. Risk Factors for cardiovascular disease during the first 2 years after renal transplantation. Transplant Proc 37 (2005) 3760
3. Rigatto C., Parfrey P., Foley R., et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 13 (2002) 1084
4. Danesh J., Collins R., and Peto R. Chronic infections and coronary artery disease: is there a link?. Lancet 350 (1997) 430
5. Eryol M.K., Kiliç H., Gül A., et al. Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?. Int Heart J 46 (2005) 205
6. Valantine H.A. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Transplantation 76 (2003) 891
7. Zhou Y.F., Leon M.B., Waclawiw M.A., et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335 (1996) 624
8. Chiu B., Vhra E., Tuckar W., et al. Chlamydia pneumonia, cytomegalovirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96 (1997) 2144
9. Knight D.A., Briggs B.R., Bennett C.F., et al. Attenuation of cytomegalovirus induced endothelial intercellular adhesion molecule-1 mRNA/protein expression and T lymphocyte adhesion by a 2′-O-methoxyethyl antisense oligonucleotide. Transplantation 69 (2000) 417
10. Potena L., Grigioni F., Ortolani P., et al. Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective threedimensional intravascular ultrasound study. Transplantation 75 (2003) 839
11. Audarda V., Matignona M., Hemeryb F., et al. Risk factors and long-term outcome of transplant renal artery stenosis in adult recipients after treatment by percutaneous transluminal angioplasty. Am J Transplant 6 (2006) 95
12. Gomez E., Laures A., Batlar J.M., et al. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation. Transplant Proc 37 (2005) 3760
13. Ligtenberg G., Hene R.J., Blankestijn P.J., et al. Cardiovascular risk factors in renal transplant patients: cyclosporine a versus tacrolimus. J Am Soc Nephrol 12 (2001) 368